Incidental Mutation 'R8822:Slc10a2'
ID 673121
Institutional Source Beutler Lab
Gene Symbol Slc10a2
Ensembl Gene ENSMUSG00000023073
Gene Name solute carrier family 10, member 2
Synonyms 9130221J18Rik, ASBT
MMRRC Submission 068655-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R8822 (G1)
Quality Score 225.009
Status Validated
Chromosome 8
Chromosomal Location 5133219-5155287 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to G at 5139149 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Glutamine to Proline at position 265 (Q265P)
Ref Sequence ENSEMBL: ENSMUSP00000023835 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000023835]
AlphaFold P70172
Predicted Effect probably damaging
Transcript: ENSMUST00000023835
AA Change: Q265P

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000023835
Gene: ENSMUSG00000023073
AA Change: Q265P

DomainStartEndE-ValueType
Pfam:SBF 39 220 1e-47 PFAM
transmembrane domain 226 248 N/A INTRINSIC
transmembrane domain 286 308 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.6%
  • 20x: 98.7%
Validation Efficiency 100% (65/65)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a sodium/bile acid cotransporter. This transporter is the primary mechanism for uptake of intestinal bile acids by apical cells in the distal ileum. Bile acids are the catabolic product of cholesterol metabolism, so this protein is also critical for cholesterol homeostasis. Mutations in this gene cause primary bile acid malabsorption (PBAM); muatations in this gene may also be associated with other diseases of the liver and intestines, such as familial hypertriglyceridemia (FHTG). [provided by RefSeq, Mar 2010]
PHENOTYPE: Mice homozygous for disruptions in this gene are essentially indistinguishable from wild-type in terms of survival, gross appearance and behavior. However, they do have defects in lipid absorption from the intestine. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 64 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adrb1 T C 19: 56,711,849 (GRCm39) V349A probably damaging Het
Atp2a2 A G 5: 122,629,772 (GRCm39) V99A possibly damaging Het
Bank1 T A 3: 135,809,640 (GRCm39) D418V possibly damaging Het
Cacna1d A G 14: 29,900,692 (GRCm39) V331A probably benign Het
Cd28 A T 1: 60,808,820 (GRCm39) N178I possibly damaging Het
Cdcp3 A T 7: 130,843,706 (GRCm39) probably null Het
Ceacam12 T C 7: 17,803,378 (GRCm39) probably benign Het
Cfap54 G A 10: 92,875,003 (GRCm39) A494V probably benign Het
Chpt1 A G 10: 88,324,268 (GRCm39) V180A probably damaging Het
Cplane1 T C 15: 8,201,262 (GRCm39) I13T probably damaging Het
Cplx3 A G 9: 57,514,471 (GRCm39) V493A probably benign Het
Cyp4a31 G A 4: 115,422,225 (GRCm39) E70K probably benign Het
Fam151a A T 4: 106,602,842 (GRCm39) M254L probably benign Het
Fyco1 A T 9: 123,648,184 (GRCm39) I1250N probably damaging Het
Gm6685 T G 11: 28,289,768 (GRCm39) Q16P probably benign Het
Gpr26 A G 7: 131,568,997 (GRCm39) Y114C probably damaging Het
Helb A T 10: 119,941,389 (GRCm39) V433D probably benign Het
Hps3 A G 3: 20,057,391 (GRCm39) W930R probably benign Het
Igdcc4 C T 9: 65,031,298 (GRCm39) T412I possibly damaging Het
Klhl35 T C 7: 99,122,055 (GRCm39) V485A probably benign Het
Lmo7 A G 14: 102,121,610 (GRCm39) D225G probably damaging Het
Myo15a C T 11: 60,367,740 (GRCm39) R167C probably damaging Het
Obp2a A T 2: 25,590,188 (GRCm39) D29V probably damaging Het
Or10d3 C A 9: 39,461,812 (GRCm39) M118I probably benign Het
Or13a22 A G 7: 140,072,926 (GRCm39) Y125C possibly damaging Het
Or52b2 A G 7: 104,986,809 (GRCm39) V38A probably benign Het
Or5d47 A G 2: 87,804,785 (GRCm39) S75P possibly damaging Het
Or8g4 A G 9: 39,661,700 (GRCm39) Y6C probably benign Het
Pde6b A G 5: 108,551,328 (GRCm39) E204G probably benign Het
Pkd1 T C 17: 24,784,615 (GRCm39) V387A probably benign Het
Pkd1l1 A T 11: 8,806,312 (GRCm39) I2054K Het
Pkp1 T A 1: 135,807,661 (GRCm39) M536L probably benign Het
Platr25 T C 13: 62,848,658 (GRCm39) E68G probably benign Het
Plxna4 T C 6: 32,127,431 (GRCm39) D1892G possibly damaging Het
Pramel30 A G 4: 144,057,092 (GRCm39) K92E probably benign Het
Prr12 A G 7: 44,699,763 (GRCm39) L76P unknown Het
Ptprz1 T A 6: 23,002,588 (GRCm39) N1559K probably damaging Het
Rbl2 A T 8: 91,833,346 (GRCm39) N750I possibly damaging Het
Rhpn2 A T 7: 35,090,228 (GRCm39) M617L probably benign Het
Rprd2 A G 3: 95,691,613 (GRCm39) S221P probably damaging Het
S100a4 T C 3: 90,512,358 (GRCm39) S14P probably benign Het
Samd11 A T 4: 156,336,764 (GRCm39) L25Q probably damaging Het
Sash1 G A 10: 8,761,615 (GRCm39) probably benign Het
Scn9a A G 2: 66,370,979 (GRCm39) S534P probably damaging Het
Sec31b C A 19: 44,507,702 (GRCm39) V781F probably benign Het
Setd1a C T 7: 127,385,332 (GRCm39) L680F possibly damaging Het
Slc27a1 T A 8: 72,033,308 (GRCm39) D283E probably damaging Het
Slc38a4 G A 15: 96,906,952 (GRCm39) T262M probably benign Het
Slc52a3 T G 2: 151,846,513 (GRCm39) V158G probably benign Het
Snx16 T C 3: 10,484,125 (GRCm39) V64A probably benign Het
Stox1 A T 10: 62,499,900 (GRCm39) W887R probably damaging Het
Tcap G A 11: 98,275,264 (GRCm39) V133M probably benign Het
Ticam1 A G 17: 56,578,444 (GRCm39) L217P probably damaging Het
Tnfrsf12a T C 17: 23,895,188 (GRCm39) S87G probably benign Het
Tyr G A 7: 87,142,330 (GRCm39) R77C probably damaging Het
Uba6 A G 5: 86,294,932 (GRCm39) probably benign Het
Usp24 G A 4: 106,269,410 (GRCm39) V2107M probably benign Het
Wdr64 T C 1: 175,544,920 (GRCm39) S118P probably damaging Het
Zbtb21 G A 16: 97,752,516 (GRCm39) T589I probably damaging Het
Zfp263 G T 16: 3,562,004 (GRCm39) probably benign Het
Zfp318 A G 17: 46,723,831 (GRCm39) T1945A probably benign Het
Zfp644 G T 5: 106,783,087 (GRCm39) R1065S possibly damaging Het
Zfp668 A T 7: 127,466,315 (GRCm39) S290T probably damaging Het
Zfp808 T A 13: 62,320,869 (GRCm39) D699E probably damaging Het
Other mutations in Slc10a2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00504:Slc10a2 APN 8 5,141,667 (GRCm39) missense probably benign 0.00
IGL00504:Slc10a2 APN 8 5,141,668 (GRCm39) missense probably damaging 0.96
IGL00596:Slc10a2 APN 8 5,141,680 (GRCm39) missense probably benign 0.00
IGL01472:Slc10a2 APN 8 5,141,652 (GRCm39) missense probably damaging 1.00
IGL02679:Slc10a2 APN 8 5,148,499 (GRCm39) missense probably damaging 1.00
gall UTSW 8 5,141,621 (GRCm39) critical splice donor site probably null
R0560:Slc10a2 UTSW 8 5,139,092 (GRCm39) missense probably benign 0.02
R0629:Slc10a2 UTSW 8 5,148,562 (GRCm39) missense probably benign 0.30
R0743:Slc10a2 UTSW 8 5,139,132 (GRCm39) missense probably damaging 0.99
R0970:Slc10a2 UTSW 8 5,155,115 (GRCm39) missense probably benign 0.00
R1033:Slc10a2 UTSW 8 5,154,889 (GRCm39) missense probably damaging 0.99
R1557:Slc10a2 UTSW 8 5,141,755 (GRCm39) missense probably damaging 1.00
R1808:Slc10a2 UTSW 8 5,154,856 (GRCm39) missense probably damaging 0.96
R3620:Slc10a2 UTSW 8 5,154,909 (GRCm39) missense probably damaging 0.99
R4084:Slc10a2 UTSW 8 5,139,126 (GRCm39) missense possibly damaging 0.71
R4112:Slc10a2 UTSW 8 5,155,135 (GRCm39) missense probably benign
R5693:Slc10a2 UTSW 8 5,155,128 (GRCm39) missense probably damaging 1.00
R6294:Slc10a2 UTSW 8 5,141,621 (GRCm39) critical splice donor site probably null
R6459:Slc10a2 UTSW 8 5,148,581 (GRCm39) splice site probably null
R7442:Slc10a2 UTSW 8 5,139,086 (GRCm39) missense possibly damaging 0.80
R8479:Slc10a2 UTSW 8 5,148,443 (GRCm39) splice site probably null
R9075:Slc10a2 UTSW 8 5,155,267 (GRCm39) start gained probably benign
R9255:Slc10a2 UTSW 8 5,148,565 (GRCm39) missense probably benign 0.00
R9493:Slc10a2 UTSW 8 5,139,047 (GRCm39) missense
Z1177:Slc10a2 UTSW 8 5,148,448 (GRCm39) missense probably damaging 1.00
Z1188:Slc10a2 UTSW 8 5,155,063 (GRCm39) missense probably damaging 0.98
Predicted Primers PCR Primer
(F):5'- CTTTCAATTTGTACAATCCACTGC -3'
(R):5'- CACCAAATATGTATGTTAAAAGCAGAC -3'

Sequencing Primer
(F):5'- TTGTACAATCCACTGCCAAAAATGG -3'
(R):5'- GGTTAGACCTAACTTGGTGAAACC -3'
Posted On 2021-04-30